Alkem labs successfully completes USFDA inspection for Taloja Bioequivalence Center
Mumbai: Alkem Laboratories Ltd. has recently announced the successful completion of U.S Food and Drug Administration (USFDA) inspection of its Taloja facility in Maharashtra
The inspection was conducted from 26th July to 28th July 2021.
"USFDA had conducted a remote and virtual Bio-Analytical inspection of the Company's Bioequivalence Center located at Taloja, Maharashtra from 26th July, 2021 to 28th July, 2021," Alkem said in a filing.
"At the end of the inspection, no Form 483 was issued," it added.
Established in 1973 and headquartered in Mumbai, Alkem is a Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.
The Company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and International markets.
Next Story
